Investment Rating - The report maintains a "Buy" rating for the company, with an expected relative increase in stock price between 10% and 20% over the next six months [6][12]. Core Views - The company reported a revenue of 480 million yuan in 2024, a year-on-year decrease of 9.6%, and a net profit attributable to shareholders of 50 million yuan, down 58.1% year-on-year. The decline in performance is attributed to intensified market competition, delayed order deliveries, and increased investments in market expansion [4][5]. - The first quarter of 2025 showed a slight recovery with revenue of 110 million yuan, a year-on-year decrease of 3.6%, and a net profit of 20 million yuan, an increase of 11.3% year-on-year [4][5]. - The testing power business generated revenue of 360 million yuan in 2024, a slight increase of 0.9%, but faced pressure on profit margins due to fierce competition. The company anticipates a recovery in this segment as overseas markets and distribution channels are further developed [5][6]. - The hydrogen energy testing equipment business underperformed with revenue of 100 million yuan in 2024, down 15.1% year-on-year. The report suggests that the development of the hydrogen energy industry and the establishment of standards will take time, but policy support is expected to enhance industry prospects [5][6]. Financial Forecasts - Revenue projections for 2025, 2026, and 2027 are 550 million yuan, 660 million yuan, and 840 million yuan, respectively. Corresponding net profits are forecasted at 70 million yuan, 90 million yuan, and 130 million yuan, leading to price-to-earnings ratios of 34, 25, and 18 times [6][10]. - The report indicates a gradual improvement in profitability, with a projected net profit margin increase from 10.3% in 2024 to 15.3% in 2027 [11]. Key Financial Metrics - The company’s asset-liability ratio stands at 24.0%, indicating a relatively low level of debt [3][11]. - The earnings per share (EPS) is expected to rise from 0.58 yuan in 2024 to 1.53 yuan in 2027, reflecting the anticipated growth in profitability [10][11]. - The report highlights a decrease in expense ratios, contributing to improved net profit margins in the first quarter of 2025 [5].

Investment Rating - The report maintains a "Buy" rating for the company, with an expected relative increase in stock price between 10% and 20% over the next six months [6][12]. Core Views - The company reported a revenue of 480 million yuan in 2024, a year-on-year decrease of 9.6%, and a net profit attributable to shareholders of 50 million yuan, down 58.1% year-on-year. The decline in performance is attributed to intensified market competition, delayed order deliveries, and increased investments in market expansion [4][5]. - In Q1 2025, the company achieved a revenue of 110 million yuan, a slight decrease of 3.6% year-on-year, while the net profit increased by 11.3% year-on-year to 20 million yuan [4][5]. - The testing power business generated revenue of 360 million yuan in 2024, with a gross margin of 44.2%, facing pressure from market competition. However, there are expectations for recovery as overseas markets and distribution channels are developed [5][6]. - The hydrogen energy testing equipment business underperformed, with revenue of 100 million yuan in 2024, down 15.1% year-on-year, but the gross margin remained stable at 46.9%. The industry is expected to improve as national policies are implemented [5][6]. Financial Forecasts - Revenue projections for 2025, 2026, and 2027 are 550 million yuan, 660 million yuan, and 840 million yuan, respectively. Corresponding net profits are forecasted to be 70 million yuan, 90 million yuan, and 130 million yuan, with price-to-earnings ratios of 34, 25, and 18 times [6][10]. - The company’s gross margin is expected to improve gradually, with projections of 47% in 2025, 47.7% in 2026, and 48.3% in 2027 [11]. Key Financial Metrics - The company’s asset-liability ratio stands at 24.0%, indicating a solid financial position [3][11]. - The earnings per share (EPS) are projected to increase from 0.58 yuan in 2024 to 1.53 yuan in 2027 [10][11]. - The company’s market capitalization is currently 2.2 billion yuan, with a total share capital of 840 million shares [3].

Core Viewpoint - The company reported a decline in revenue and net profit for 2024 and Q1 2025, indicating challenges in the market and increased competition in the downstream new energy sector [1][2]. Financial Performance - For 2024, the company generated revenue of 478 million yuan, a year-on-year decrease of 9.6%, and a net profit of 49 million yuan, down 58.1% [1]. - In Q1 2025, revenue was 107 million yuan, a year-on-year decline of 3.6% but a quarter-on-quarter increase of 6.0%. The net profit was 20 million yuan, reflecting a year-on-year growth of 11.3% [1]. Industry Trends - The demand for testing power supplies in the downstream new energy sector is slowing, with 2024 revenue from testing power supplies at 365 million yuan, a mere 1% increase year-on-year, attributed to pressure on profitability for downstream new energy vehicle and energy storage manufacturers [2]. - The hydrogen energy testing power supply segment saw a revenue of 95 million yuan in 2024, down 15% year-on-year, with weak demand in the fuel cell sector but high growth in electrolyzer testing power supply demand [2]. Profitability Metrics - The gross margin for Q1 2025 was 37.6%, a decrease of 13.6 percentage points year-on-year due to industry price competition. The company maintained good control over expense ratios, with sales, management, R&D, and financial expense ratios at 12.9%, 10.8%, 16.4%, and -1.1%, respectively [3]. - The net profit margin for Q1 2025 was 19.0%, an increase of 2.6 percentage points year-on-year [3]. Profit Forecast and Valuation - Due to intense price competition, the net profit forecast for 2025 has been revised down by 4% to 109 million yuan, with a new estimate for 2026 at 170 million yuan. The current stock price corresponds to a P/E ratio of 20.2 for 2025 and 13.0 for 2026 [4]. - The company maintains an outperform rating and a target price of 30 yuan, implying a potential upside of 13.9% from the current stock price [4].